BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29788341)

  • 21. Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia.
    Dolzhikova IV; Zubkova OV; Tukhvatulin AI; Dzharullaeva AS; Tukhvatulina NM; Shcheblyakov DV; Shmarov MM; Tokarskaya EA; Simakova YV; Egorova DA; Scherbinin DN; Tutykhina IL; Lysenko AA; Kostarnoy AV; Gancheva PG; Ozharovskaya TA; Belugin BV; Kolobukhina LV; Pantyukhov VB; Syromyatnikova SI; Shatokhina IV; Sizikova TV; Rumyantseva IG; Andrus AF; Boyarskaya NV; Voytyuk AN; Babira VF; Volchikhina SV; Kutaev DA; Bel'skih AN; Zhdanov KV; Zakharenko SM; Borisevich SV; Logunov DY; Naroditsky BS; Gintsburg AL
    Hum Vaccin Immunother; 2017 Mar; 13(3):613-620. PubMed ID: 28152326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pregnancy Outcomes among Women Receiving rVSVΔ-ZEBOV-GP Ebola Vaccine during the Sierra Leone Trial to Introduce a Vaccine against Ebola.
    Legardy-Williams JK; Carter RJ; Goldstein ST; Jarrett OD; Szefer E; Fombah AE; Tinker SC; Samai M; Mahon BE
    Emerg Infect Dis; 2020 Mar; 26(3):541-548. PubMed ID: 32017677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The year that Ebola virus took over west Africa: missed opportunities for prevention.
    Bausch DG
    Am J Trop Med Hyg; 2015 Feb; 92(2):229-232. PubMed ID: 25561568
    [No Abstract]   [Full Text] [Related]  

  • 24. Power, fairness and trust: understanding and engaging with vaccine trial participants and communities in the setting up the EBOVAC-Salone vaccine trial in Sierra Leone.
    Enria L; Lees S; Smout E; Mooney T; Tengbeh AF; Leigh B; Greenwood B; Watson-Jones D; Larson H
    BMC Public Health; 2016 Nov; 16(1):1140. PubMed ID: 27821112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel Ordered Stepped-Wedge Cluster Trial Designs for Detecting Ebola Vaccine Efficacy Using a Spatially Structured Mathematical Model.
    Diakite I; Mooring EQ; Velásquez GE; Murray MB
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004866. PubMed ID: 27509037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and Immunogenicity of Novel Adenovirus Type 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized Clinical Trial.
    Milligan ID; Gibani MM; Sewell R; Clutterbuck EA; Campbell D; Plested E; Nuthall E; Voysey M; Silva-Reyes L; McElrath MJ; De Rosa SC; Frahm N; Cohen KW; Shukarev G; Orzabal N; van Duijnhoven W; Truyers C; Bachmayer N; Splinter D; Samy N; Pau MG; Schuitemaker H; Luhn K; Callendret B; Van Hoof J; Douoguih M; Ewer K; Angus B; Pollard AJ; Snape MD
    JAMA; 2016 Apr; 315(15):1610-23. PubMed ID: 27092831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attitudes about vaccines to prevent Ebola virus disease in Guinea at the end of a large Ebola epidemic: Results of a national household survey.
    Irwin KL; Jalloh MF; Corker J; Alpha Mahmoud B; Robinson SJ; Li W; James NE; Sellu M; Jalloh MB; Diallo AA; Tracy L; Hajjeh R; VanSteelandt A; Bunnell R; Martel L; Raghunathan PL; Marston B;
    Vaccine; 2017 Dec; 35(49 Pt B):6915-6923. PubMed ID: 28716555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infectious Disease. Ebola vaccines racing forward at record pace.
    Cohen J
    Science; 2014 Sep; 345(6202):1228-9. PubMed ID: 25214582
    [No Abstract]   [Full Text] [Related]  

  • 29. The Ebola Epidemic. High hopes for Guinean vaccine trial.
    Enserink M
    Science; 2015 Jan; 347(6219):219-20. PubMed ID: 25593164
    [No Abstract]   [Full Text] [Related]  

  • 30. 'When Ebola enters a home, a family, a community': A qualitative study of population perspectives on Ebola control measures in rural and urban areas of Sierra Leone.
    Gray N; Stringer B; Bark G; Heller Perache A; Jephcott F; Broeder R; Kremer R; Jimissa AS; Samba TT
    PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006461. PubMed ID: 29883449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New Ebola vaccine trial is underway.
    Perspect Public Health; 2015 Mar; 135(2):59. PubMed ID: 25759318
    [No Abstract]   [Full Text] [Related]  

  • 32. Infectious diseases. The Ebola vaccine underdog.
    Link C; Cohen J
    Science; 2014 Oct; 346(6209):534. PubMed ID: 25359944
    [No Abstract]   [Full Text] [Related]  

  • 33. Ebola lessons: Did prior epidemic experience protect against the spread of COVID-19 in Sierra Leone?
    McLean KE
    Med Anthropol Q; 2024 Jun; 38(2):164-178. PubMed ID: 38386863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ebola: Anatomy of an Epidemic.
    Lo TQ; Marston BJ; Dahl BA; De Cock KM
    Annu Rev Med; 2017 Jan; 68():359-370. PubMed ID: 27813879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Containing Ebola at the Source with Ring Vaccination.
    Merler S; Ajelli M; Fumanelli L; Parlamento S; Pastore Y Piontti A; Dean NE; Putoto G; Carraro D; Longini IM; Halloran ME; Vespignani A
    PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005093. PubMed ID: 27806049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infectious diseases. In Guinea, a long, difficult road to zero Ebola cases.
    Enserink M
    Science; 2015 May; 348(6234):485-6. PubMed ID: 25931530
    [No Abstract]   [Full Text] [Related]  

  • 37. Real-time dynamic modelling for the design of a cluster-randomized phase 3 Ebola vaccine trial in Sierra Leone.
    Camacho A; Eggo RM; Goeyvaerts N; Vandebosch A; Mogg R; Funk S; Kucharski AJ; Watson CH; Vangeneugden T; Edmunds WJ
    Vaccine; 2017 Jan; 35(4):544-551. PubMed ID: 28024952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical development of a recombinant Ebola vaccine in the midst of an unprecedented epidemic.
    Coller BG; Blue J; Das R; Dubey S; Finelli L; Gupta S; Helmond F; Grant-Klein RJ; Liu K; Simon J; Troth S; VanRheenen S; Waterbury J; Wivel A; Wolf J; Heppner DG; Kemp T; Nichols R; Monath TP
    Vaccine; 2017 Aug; 35(35 Pt A):4465-4469. PubMed ID: 28647166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knowledge and attitudes about Ebola vaccine among the general population in Sierra Leone.
    Huo X; Shi G; Li X; Lai X; Deng L; Xu F; Chen M; Wei Q; Samba T; Liang X
    Vaccine; 2016 Apr; 34(15):1767-72. PubMed ID: 26928073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "We are the heroes because we are ready to die for this country": Participants' decision-making and grounded ethics in an Ebola vaccine clinical trial.
    Tengbeh AF; Enria L; Smout E; Mooney T; Callaghan M; Ishola D; Leigh B; Watson-Jones D; Greenwood B; Larson H; Lees S
    Soc Sci Med; 2018 Apr; 203():35-42. PubMed ID: 29544144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.